Literature DB >> 27176680

New insulin preparations: A primer for the clinician.

Luigi Meneghini1.   

Abstract

The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.
Copyright © 2016 Cleveland Clinic.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27176680     DOI: 10.3949/ccjm.83.s1.05

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  5 in total

Review 1.  Novel Concentrated Insulin Delivery Devices: Developments for Safe and Simple Dose Conversions.

Authors:  Jeremy L Johnson; Jessica M Downes; Cassandra K Obi; Nana B Asante
Journal:  J Diabetes Sci Technol       Date:  2016-11-28

2.  Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer.

Authors:  Himgauri Naik; Ted Gauthier; Sitanshu Singh; Seetharama Jois
Journal:  Bioorg Med Chem Lett       Date:  2018-10-03       Impact factor: 2.823

Review 3.  The Challenges of Electronic Health Records and Diabetes Electronic Prescribing: Implications for Safety Net Care for Diverse Populations.

Authors:  Neda Ratanawongsa; Lenny L S Chan; Michelle M Fouts; Elizabeth J Murphy
Journal:  J Diabetes Res       Date:  2017-01-18       Impact factor: 4.011

Review 4.  Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care.

Authors:  Sanjay Kalra; Leszek Czupryniak; Gary Kilov; Roberta Lamptey; Ajay Kumar; A G Unnikrishnan; Aissa Boudiba; Mohamed Abid; Zhanay A Akanov; Ali Latheef; Mustafa Araz; Ralph Audehm; Silver Bahendeka; Naby Balde; Sandeep Chaudhary; Chaicharn Deerochanawong; Olufemi Fasanmade; Hinde Iraqi; Tint Swe Latt; Jean Claude Mbanya; Joel Rodriguez-Saldana; Ko Seung Hyun; Zafar A Latif; Maxim Lushchyk; Magdy Megallaa; Mohammed Wali Naseri; Nguyen Quang Bay; Kaushik Ramaiya; Hoosen Randeree; Syed Abbas Raza; Khalid Shaikh; Dina Shrestha; Eugene Sobngwi; Noel Somasundaram; Norlela Sukor; Rima Tan
Journal:  Diabetes Ther       Date:  2018-11-03       Impact factor: 2.945

Review 5.  Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist.

Authors:  Dhiren Patel; Curtis Triplitt; Jennifer Trujillo
Journal:  Adv Ther       Date:  2019-03-21       Impact factor: 3.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.